To evaluate whether pharmacological inhibition of AR alleviates DbCM, we assessed cardiac structure and function in vivo by ultrasound echocardiography in mice subjected to experimental type 2 diabetes. The gene discussed is AR; the disease is type 2 diabetes mellitus.